A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes

Clinical trial NCT04594941 · COMPLETED

Trial details

NCT number: NCT04594941
Sponsor: GE Healthcare
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease (CAD)Ischemic Heart Disease

Start date: 2022-01-27
Primary completion: 2022-05-26
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.